David J. Mazzo

CIK: 0001334549

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)9 (75.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LSTA

LISATA THERAPEUTICS, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Award(A)
Direct
81K shares-
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Tax Payment(F)
Direct
10.5K shares at avg. $1.97$21K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Tax Payment(F)
Direct
10.5K shares at avg. $1.97$21K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Tax Payment(F)
Direct
12.2K shares at avg. $1.97$24K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Tax Payment(F)
Direct
7.9K shares at avg. $1.97$15K
LSTA
LISATA THERAPEUTICS, INC.
Jan 10, 2025
Tax Payment(F)
Direct
3.1K shares at avg. $3.73$12K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2025
Award(A)
Direct
81K shares-
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2025
Tax Payment(F)
Direct
9.4K shares at avg. $3.80$36K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2025
Tax Payment(F)
Direct
10.9K shares at avg. $3.80$42K
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2025
Tax Payment(F)
Direct
7K shares at avg. $3.80$27K
LSTA
LISATA THERAPEUTICS, INC.
Oct 1, 2024
Tax Payment(F)
Direct
27K shares at avg. $2.93$79K
LSTA
LISATA THERAPEUTICS, INC.
Oct 1, 2024
Award(A)
Direct
58K shares at avg. $2.93$170K

		Type	Shares	Price		Ownership
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Award(A)	81,000	-	$0	Direct
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	10,503	$1.97	$20,691	Direct
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	10,515	$1.97	$20,715	Direct
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	12,224	$1.97	$24,081	Direct
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	7,854	$1.97	$15,472	Direct
Jan 10, 2025	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	3,106	$3.73	$11,585	Direct
Jan 9, 2025	LSTA LISATA THERAPEUTICS, INC.	Award(A)	81,000	-	$0	Direct
Jan 9, 2025	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	9,414	$3.80	$35,773	Direct
Jan 9, 2025	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	10,925	$3.80	$41,515	Direct
Jan 9, 2025	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	7,017	$3.80	$26,665	Direct
Oct 1, 2024	LSTA LISATA THERAPEUTICS, INC.	Tax Payment(F)	26,964	$2.93	$79,005	Direct
Oct 1, 2024	LSTA LISATA THERAPEUTICS, INC.	Award(A)	58,000	$2.93	$169,940	Direct

1-12 of 12 transactions

About Mazzo David J

Mazzo David J (SEC CIK 0001334549) files insider reports with the SEC as President & CEO of LISATA THERAPEUTICS, INC. (LSTA).

Signal8 holds 3 ownership filings by Mazzo David J, all Form 4s, filed between Oct 2, 2024 and Jan 13, 2026. Those filings report 12 transactions, from Oct 1, 2024 to Jan 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mazzo David J's filings is in BASKING RIDGE, NJ.

Recent filings by Mazzo David J

Jan 9, 2026: Grant or award of LSTA shares (Form 4, code A).
Jan 9, 2026: Tax withholdings of LSTA shares (4 lines, Form 4, code F).
Jan 10, 2025: Tax withholding of LSTA shares (Form 4, code F).
Jan 9, 2025: Grant or award of LSTA shares (Form 4, code A).
Jan 9, 2025: Tax withholdings of LSTA shares (3 lines, Form 4, code F).

Other insiders filing for LISATA THERAPEUTICS, INC. (LSTA)

Farrow Jeffrey S, Director
LOVE TED W, Director
Lehrer-Graiwer Joshua, President & COO
Nisco James, SVP, Fin/Treas, Chief Actg Off
Imam Tariq, SVP, Bus Dev, General Counsel
Buck Kristen K, EVP, R&D and CMO

How to read Form 4 transaction codes